Robert Verhagen, CEO

Robert brings to CCAB more than 20 years of business and leadership expertise in the pharmaceutical and diagnostics fields. Most notably, he was the CEO at Helix Biopharma where he led the reorganization of the company, raising over $30 million and advancing its NSCLC candidate through early stage clinical trials.

Robert sits on the Portfolio Development Committee for InnovateCalgary, providing diligence and advice to early-stage companies involved in all areas of new technology development, from life sciences to cleantech. He has held executive or senior management roles at Spectral Medical Inc., MDS Inc., and founded INH Technologies Inc. Robert has raised over $45 million for various companies and had led the licensing or acquisition of six therapeutics.

Email: Robert.Verhagen@ccabcanada.com